Slide 1: Faster, more accurate gold analysis
Faster, more accurate gold analysis 1H FY23 Results 23 February 2023 Dirk Treasure, Managing Director and CEO Brett Coventry, CFO
Slide 2: Important notice
Important notice The material in this presentation has been prepared by Chrysos Corporation Limited (ASX: C79) (“Chrysos” or the “Group") and is general background information about Chrysos’ current activities as at the date of this presentation. The information is given in summary form and does not
Slide 3: Chrysos – revolutionising the global mining industry
Chrysos – revolutionising the global mining industry Chrysos is a global provider of novel assay services through its proprietary PhotonAssayTM technology Disruptive Minerals Analysis Service and Lease Model with Industry Accepted Technology Technology Tier 1 Counterparties Displacing Traditional Fi
Slide 4: Agenda
Agenda 01 1H FY23 Results Highlights 02 1H FY23 Financial Summary 03 Outlook 04 Questions 05 About Chrysos
Slide 5: 1H FY23 Results Highlights
1H FY23 Results Highlights [Insert]
Slide 6: 1H FY23 results
1H FY23 results On track to meet FY23 Prospectus forecasts $11.5m $0.63m $714m Total Unaudited Revenue EBITDA Total Contract Value (TCV) • +109% growth on 1H FY22 (+$5.5m) • +$0.59m growth on 1H FY22 ($0.04m) • Deepening customer base • MMAP/AAC Revenue of $11.0m • Driven by an increasing number of
Slide 7: Revenue momentum continuing
Revenue momentum continuing Strong growth in baseline and additional revenue Unaudited MMAP, AAC & Other Revenue ■ Minimum Monthly Assay Payments (MMAP) provide predictable $14,000 and sustainable minimum revenue $11.5m $12,000 ■ MMAP was $8.8m, up 103% on 1H FY22 ($4.3m) ■ Combined MMAP of $1.7m pe
Slide 8: Executing on our global PhotonAssay roll out
Executing on our global PhotonAssayTM roll out Strong and sustainable growth underpinned by long-term annuity-style recurring revenue 15 Units Deployed1 Average Unit Utilisation & Samples Processed 80% 350,000 Samples Processed - Monthly 70% 300,000 60% 250,000 Average Utilisation 50% 200,000 40% 15
Slide 9: 1H FY23 Financial Summary
1H FY23 Financial Summary [Insert]
Slide 10: Strong sales pipeline ahead
Strong sales pipeline ahead Continued adoption of PhotonAssayTM by global laboratories and miners Customers Total Contract Value1, 2 Intertek MSALABS ALS 800 1 700 600 Britannia Mining Solutions 500 400 Laboratories Alfred H Knight SGS 300 200 100 Barrick Gold Corporation 0 2 Agnico Eagle Ravenswood
Slide 11: Revenue & profitability
Revenue & profitability 1H FY23 Results Commentary #039;000 1H FY22 1H FY23 Revenue and other income ■ Total Revenue of $11.5m continues to grow in line with deployment of Revenue 5,521 10,976 PhotonAssay™ units Other revenue - 560 ■ Growth in Total Revenue of 109% exceeds growth in expenses of 72% Tot
Slide 12: Cash flow summary
Cash flow summary Chrysos is operationally cash-flow positive Pro forma historical and forecast cash flow summary Commentary $000’s 1H FY22 1H FY23 ■ Positive operating cash flow of $3.8m to be reinvested into additional PhotonAssay™ units. Cash flow will continue to fluctuate, depending on EBITDA 3
Slide 13: Balance sheet
Balance sheet Strong balance sheet provides a solid platform to accelerate growth Commentary $000’s 30 June 22 31 Dec 22 Assets ■ Balance sheet remains in a strong position to continue to Cash and cash equivalents 92,104 81,091 deploy PhotonAssay™ units, now supported by an increased debt facility w
Slide 14: Outlook
CHRYSOS CORPO! Assays at the
Slide 15: Outlook
Outlook Chrysos is well-positioned for sustained growth through FY23 and beyond ■ Demand for Chrysos’ PhotonAssayTM technology remains robust, supporting sales growth and unit deployments into 2025 ■ On track to meet FY23 Prospectus targets: • Total Revenue: $26.6m • EBITDA: $3.2m • 21 deployed unit
Slide 16: About Chrysos
About Chrysos [Insert]
Slide 17: Our commercialisation journey
Our commercialisation journey The outcome of 20+ years of research and development Prototype Complete JORC and NI43-101 New Customer Announcements 1st PhotonAssayTM Max unit Companies cite PhotonAssayTM data Barrick Bulyanhulu in Tanzania contracts in market announcements MSALABS and PhotonAssayTM P
Slide 18: The Chrysos Vision
The Chrysos Vision To become the world’s leading provider of innovative assay services and technologies Market Challenge: Traditional assay techniques are slow, labour intensive, complex, destructive to the assay sample, and involve Fully-quantitative analysis in as little as 2 minutes! dangerously
Slide 19: PhotonAssay technology
PhotonAssayTM technology Best in class gold assaying with measurable benefits over traditionally used methods PhotonAssayTM vs. Traditional Fire Assay1 PhotonAssayTM value proposition Fire Assay PhotonAssayTM Faster turnaround Lower costs Simple to operate Results in as little as 2 minutes Time per
Slide 20: Large & unpenetrated TAM
Large & unpenetrated TAM Assay expenditure is a non-discretionary operating cost Existing PhotonAssayTM Reach TAM for PhotonAssayTM Units 700 610 Units 600 500 PhotonAssayTM Unit 410 On-site 400 Laboratories +561 Units Units 300 200 Off-site 100 200 Laboratories 49 0 Installed / Contracted Base TAM
Slide 21: Delivering tangible benefits for miners
Delivering tangible benefits for miners PhotonAssayTM enables timely decision making and additional gold recovery The opportunity… PhotonAssayTM is embedded in the mining value chain PhotonAssayTM Value Add ■ Each year global miners are Exploration Fast turnaround for mine estimated to lose >$2.0 bi
Slide 22: An environmentally-friendly solution
An environmentally-friendly solution Substantially better for the environment and significantly safer than fire assay PhotonAssayTM has a substantial positive environmental impact that will continue to grow in tandem with the uptake of the technology PhotonAssayTM reduces CO2 emissions and elimina
Slide 23: High barriers to entry
High barriers to entry High barriers to entry supported by global IP rights Barriers to competitive entry Long-term leases with Protected by global guaranteed minimums, IP rights embedded at customer site 20+ years of R&D and Superior product to the investment in technology alternative Attractive va
Slide 24: Clear growth pathway
Clear growth pathway Clear organic growth plan with potential to expand TAM through additional commodities Business development pipeline Multi-commodity assaying ■ Global networks of laboratories Potential to expand TAM Potential to increase profitability Intertek ALS SGS MSALABS ■ Base metals ■ Add
Slide 25: Experienced leadership team
Experienced leadership team Supported by a well respected and tenured board Senior leadership team Board of Directors Dirk Treasure Rob Adamson Kerry Gleeson Founding CEO & Managing Director Founder & Chairman Director • Metallurgist with a background in both • 20+ years’ experience in mining and •
Slide 26: Thank you
Thank you For more information, please visit chrysos.com.au or contact us at investors@chrysos.com.au